Skip to main content

Table 6 Recommendation summary – Monitoring recommendations for patients with established CKD

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

 

CEBAM

ACP

HAS

KDIGO

KHA-CARI

BCMA

UMHS

VA-DoD

NICE

2012

2013

2013

2013

2013

2014

2014

2014

2015

Monitoring patients with known CKD

frequency (times /year)

 G1/A1

1

  

1

 

1

1

 

≤1

 G1/A2

1

  

1

 

1

1

 

1

 G1/A3

1

  

2

 

2

2

 

≥1

 G2/A1

1

  

1

 

1

1

 

≤1

 G2/A2

1

  

1

 

1

1

 

1

 G2/A3

2

  

2

 

2

2

 

≥1

 G3a/A1

2

  

1

 

1

1

 

1

 G3a/A2

2

  

2

 

2

2

 

1

 G3a/A3

2

  

3

 

3

3

 

2

 G3b/A1

2

  

2

 

2

2

 

≤2

 G3b/A2

2

  

3

 

3

3

 

2

 G3b/A3

≥4

  

3

 

3

3

 

≥2

 G4/A1

≥4

  

3

 

3

4**

 

2

 G4/A2

≥4

  

3

 

3

3

 

2

 G4/A3

≥4

  

≥4

 

≥4

≥4

 

3

 G5/A1

≥4

  

≥4

 

≥4

≥4

 

4

 G5/A2

≥4

  

≥4

 

≥4

≥4

 

≥4

 G5/A3

≥4

  

≥4

 

≥4

≥4

 

≥4

parameter

 blood pressure

*

*

 

*

 

*

 weight

     

   

 (e)GFR

 

 

 albuminuria/proteinuria/ACR

 

 

 complete blood count

     

   

 iron saturation

     

   

 HbA1c

     

   

 serum calcium

     

   

 serum phosphorus

     

   

 serum potassium

     

i

i

  

 serum albumin

     

   

 complications

        

 inulin

        

i

 51Cr-EDTA

        

i

 125I-iothalamate

        

i

 iohexol

        

i

 cardiovascular risk

  

  

▪➢

   

 smoking status

     

   

 medication

 

   

   

 psychosocial health

     

   
  1. ▪ recommendation, − negative recommendation, i: when indicated, *not specifically mentioned, but obvious from the context (e.g. blood pressure targets), **probably transcription error, ➢ refers to British Columbian guideline “Cardiovascular disease - primary prevention”
  2. Stages of CKD: G1, glomerular filtration rate of ≥90 ml/min/1.73m2; G2, 60–89 ml/min/1.73m2; G3a, 45–59 ml/min/1.73m2; G3b, 30–44 ml/min/1.73m2; G4, 15–29 ml/min/1.73m2; G5, < 15 ml/min/1.73m2
  3. Albuminuria stages of CKD: A1, albumine-creatinine-ratio < 3 mg/mmol; A2, 3–30 mg/mmol; A3, > 30 mg/mmol
  4. ACR albumin-creatinine-ratio, eGFR estimated glomerular filtration rate, HbA1c glycated hemoglobin, 51Cr-EDTA chromium-51-ethylenediaminetetraacetic acid
  5. American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasiansians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)